Clinical trial
Clinical Trial of Human (Allogeneic) iPS Cell-derived Cardiomyocytes Sheet for Ischemic
NCT04696328 is registered in ClinicalTrials.gov with Osaka University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Trial of Human (Allogeneic) iPS Cell-derived Cardiomyocytes Sheet for Ischemic
- Lead sponsor
- Osaka University
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- December 2, 2019
- Completion date
- May 30, 2023
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.